HOME >> BIOLOGY >> NEWS
Laboratory professionals in Africa receive training under AIDS Relief Plan

CHICAGO (September 28, 2005) The American Society for Clinical Pathology (ASCP) announced that the Society will receive approximately $1.5 million in federal funds to continue to provide laboratory training and quality improvement programs in African countries severely affected by AIDS. The training programs are for medical laboratory professionals in Africa and will continue in 2006 through the President's Emergency Plan for AIDS Relief.

The funding comes from the United States Department of Health and Human Services Centers for Disease Control and Prevention (HHS/CDC). The money will allow the Chicago-based ASCP to continue its involvement in a cooperative agreement program with CDC. ASCP's role in the program is to provide laboratory training and quality improvement programs for diagnosis and laboratory monitoring of HIV/AIDS patients in resource-limited countries as part of the Emergency Plan.

"Ultimately, this program will serve to enhance laboratory testing practices and the quality of laboratory testing services, in order to improve the effectiveness of HIV diagnostic, care, and treatment services and interventions," said LoAnn Peterson, MD, FASCP, ASCP President. The award will be made for a 12-month budget period, within a project period of up to four years.

The Emergency Plan is a $15 billion international relief effort. In addition to Ethiopia and Zambia, targeted nations include Botswana, Ivory Coast, Kenya, Mozambique, Namibia, Nigeria, Rwanda, South Africa, Tanzania, Uganda, Haiti, Guyana, Zambia, Lesotho, Swaziland and Viet Nam. ASCP will be working in Ethiopia, Tanzania, South Africa, Zambia, Lesotho and Swaziland.

In the past year, 14 ASCP volunteer members have played roles assessing the situation in Africa, serving as trainers, and participating in Work Groups developing training materials.

Estimates are that some 40 million people are living with HIV/AIDS in developing nations. In Zambia, for instan
'"/>

Contact: Nadine Filipiak
NadineF@ascp.org
312-738-4883
American Society for Clinical Pathology
28-Sep-2005


Page: 1 2

Related biology news :

1. Story tips from the US Department of Energys Oak Ridge National Laboratory, August 2007
2. Story tips from the Department of Energys Oak Ridge National Laboratory
3. Psychiatric Genomics Center established at Cold Spring Harbor Laboratory
4. Los Alamos National Laboratory making progress in Groundwater Protection Program
5. Bigelow Laboratory Scientists develop new approach to study marine microbes
6. Jackson Laboratory researcher receives JDRFs Grodsky award
7. Story tips from the Department of Energys Oak Ridge National Laboratory, April 2007
8. Story tips from the Department of Energys Oak Ridge National Laboratory, March 2007
9. Story tips from the Department of Energys Oak Ridge National Laboratory
10. Cold Spring Harbor Laboratory scientists discover new gene that prevents multiple types of cancer
11. Story tips from the Department of Energys Oak Ridge National Laboratory, January 2007

Post Your Comments:
(Date:5/23/2013)... in treating cerebral palsy with autologous cord blood. Following ... year old boy had been in a persistent vegetative ... months after treatment with the cord blood containing stem ... the child learned to speak simple sentences and to ... study, dispel the long-held doubts about the effectiveness of ...
(Date:5/23/2013)... fastest growing open-access publishers, announces the launch of ... Biotechnology . , A broad scope journal ... Biotechnology will provide a single open-access platform ... to be disseminated and discussed. , ... an open-science and interactive web platform for the ...
(Date:5/23/2013)... when microbial pathogens are growing increasingly resistant to the ... of Wisconsin scientists has synthesized a potent new class ... staph infections. , Writing online in the Journal ... by University of Wisconsin-Madison chemistry Professor Helen Blackwell describes ... of Staphylococcus aureus , a bacterium at the ...
Breaking Biology News(10 mins):First successful treatment of pediatric cerebral palsy with autologous cord blood 2Frontiers launches new open-access journal in Bioengineering and Biotechnology 2University of Wisconsin chemists find new compounds to curb staph infection 2
(Date:5/23/2013)... BioTrends Research Group, one of the ... biopharmaceutical issues, finds that, unaided, one in five ... that in the past six months, they have ... anticipation of the next generation of HCV treatments—notably ... 6 percent reported that they had begun warehousing ...
(Date:5/23/2013)... May 23, 2013 Northwest Biotherapeutics (NASDAQ: ... DCVax ® personalized immune therapies for solid tumor ... at this year,s American Society Of Clinical Oncology (ASCO) ... its leadership role in immune therapy.  (Logo: ... meeting is the pre-eminent conference focused on clinical treatment ...
(Date:5/23/2013)...  Verenium Corporation (Nasdaq: VRNM ), a ... commercialization of high-performance enzymes, today announced that ... at two upcoming conferences. (Logo: http://photos.prnewswire.com/prnh/20120924/MM79973LOGO ... Second Annual Marcum LLP Microcap Conference on Thursday, May ... York City.  The presentation is scheduled to begin at ...
(Date:5/23/2013)... May 23, 2013 SynCardia Systems, Inc. ... only FDA, Health Canada and CE (Europe) approved Total ... in Scotland, which boasts more than 380,000 visitors annually, ... powered by the Freedom® portable driver as part ... most advanced exhibitions of its kind. , “BodyWorks ...
Breaking Biology Technology:The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Verenium To Present At Two Upcoming Conferences 2Verenium To Present At Two Upcoming Conferences 3SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 2SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 3
Cached News: